Descrizione

Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment.

Figure 6

Chart

Source Paper

Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in zebrafish models.

PloS one (2022)

PMID: 35171916

DOI: 10.1371/journal.pone.0262942

Cite This Figure

![Figure 6: Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment.]()

> Source: Meng Chen et al. "Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in ." *PloS one*, 2022. PMID: [35171916](https://pubmed.ncbi.nlm.nih.gov/35171916/)

<figure>
  <img src="" alt="Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment." />
  <figcaption>Figure 6. Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment.<br>  Source: Meng Chen et al. "Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in ." <em>PloS one</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35171916/">35171916</a></figcaption>
</figure>

Evidenze correlate

Bifidobacterium lactis per Chronic Constipation

Grado B · 4 studi